Non-invasive biomarkers of lung inflammation in smoking subjects

Keyphrases

• Lung 100%
• Lung Inflammation 100%
• Cigarette Smoking 100%
• Induced Sputum 100%
• Exhaled Breath Condensate 100%
• Lung Damage 100%
• Healthy Smokers 100%
• Fractional Exhaled Nitric Oxide (FeNO) 100%
• Pulmonary Inflammation 100%
• Non-invasive Biomarkers 100%
• Electronic Nose (E-nose) 100%
• Oxidative Stress 50%
• High Risk 50%
• Lung Cancer 50%
• Tobacco 50%
• Cell Analysis 50%
• Inflammatory Response 50%
• Biomolecules 50%
• Risk Factors 50%
• Early Identification 50%
• Secondary Prevention 50%
• Non-smokers 50%
• Golden Standard 50%
• Tissue Injury 50%
• Non-invasive Method 50%
• Chronic Obstructive Pulmonary Disease 50%
• Prevention Strategies 50%
• Damage Process 50%
• Volatile Organic Compounds 50%
• Bronchoscopy 50%
• Respiratory Inflammation 50%
• Respiratory Pathology 50%
• Bronchial Biopsy 50%
• Tobacco Smoke Exposure 50%
• Compound Patterns 50%
• Analytical Validation 50%
• Sputum Supernatant 50%
• Longitudinal Sampling 50%
• Breath Volatiles 50%
• Tissue Dysfunction 50%

Medicine and Dentistry

• Biological Marker 100%
• Nitric Oxide 100%
• Cigarette Smoking 100%
• Induced Sputum 100%
• Exhaled Breath Condensate 100%
• Electronic Nose 100%
• Lung 100%
• Serositis 50%
• Breathing 50%
• Oxidative Stress 50%
• Lung Cancer 50%
• Secondary Prevention 50%
• Non Invasive Procedure 50%
• Chronic Obstructive Pulmonary Disease 50%
• Tissue Injury 50%
• Bronchoscopy 50%
• Sputum 50%
• Volatile Organic Compound 50%
• Bronchus Biopsy 50%